markets · · seekingalpha.com
Texas Instruments: Broader Recovery And Lower Capex Support Further Upside
Texas Instruments is rated Buy, supported by broad analog and embedded recovery, rising factory utilization, and moderating capex. TXN posted accelerating revenue and margin growth, with Q2 FY2026 gross margin at 61.4% and operating margin at 42.3%. Lower FY2026 capex guidance ($2B–$3B) and improved utilization support earnings and free cash flow growth despite a sector premium valuation.
Texas Instruments is rated Buy, supported by broad analog and embedded recovery, rising factory utilization, and moderating capex. TXN posted accelerating revenue and margin growth, with Q2 FY2026 gross margin at 61.4% and operating margin at 42.3%. Lower FY2026 capex guidance ($2B–$3B) and improved utilization support earnings and free cash flow growth despite a sector premium valuation.
- #TXN